Literature DB >> 32187523

Acromegaly and Vertebral Fractures: Facts and Questions.

Andrea Giustina1.   

Abstract

Here I review vertebral fractures (VFs) as an emerging complication of acromegaly through a pathway of key questions in order to help clinicians manage the disease. Peculiarities of acromegalic osteopathy are that VFs are common but not explained by low bone mineral density (BMD) being related to disease duration and activity, and occurring even after remission.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  acromegaly; bone; growth hormone; insulin-like growth factor 1; morphometry; vertebral fractures

Year:  2020        PMID： 32187523     DOI： 10.1016/j.tem.2020.01.011

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN： 1043-2760            Impact factor:   12.015


  12 in total

Review 1.  The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective.

Authors:  Pietro Mortini; Gianluca Nocera; Francesca Roncelli; Marco Losa; Anna Maria Formenti; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 2.  Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.

Authors:  Cláudia Ribeiro de Moura; Sara Campos Lopes; Ana Margarida Monteiro
Journal:  Pituitary       Date:  2022-07-22       Impact factor: 3.599

Review 3.  Multidisciplinary management of acromegaly: A consensus.

Authors:  Andrea Giustina; Garni Barkhoudarian; Albert Beckers; Anat Ben-Shlomo; Nienke Biermasz; Beverly Biller; Cesar Boguszewski; Marek Bolanowski; Jens Bollerslev; Vivien Bonert; Marcello D Bronstein; Michael Buchfelder; Felipe Casanueva; Philippe Chanson; David Clemmons; Maria Fleseriu; Anna Maria Formenti; Pamela Freda; Monica Gadelha; Eliza Geer; Mark Gurnell; Anthony P Heaney; Ken K Y Ho; Adriana G Ioachimescu; Steven Lamberts; Edward Laws; Marco Losa; Pietro Maffei; Adam Mamelak; Moises Mercado; Mark Molitch; Pietro Mortini; Alberto M Pereira; Stephan Petersenn; Kalmon Post; Manuel Puig-Domingo; Roberto Salvatori; Susan L Samson; Ilan Shimon; Christian Strasburger; Brooke Swearingen; Peter Trainer; Mary L Vance; John Wass; Margaret E Wierman; Kevin C J Yuen; Maria Chiara Zatelli; Shlomo Melmed
Journal:  Rev Endocr Metab Disord       Date:  2020-09-10       Impact factor: 6.514

Review 4.  Hyperprolactinemia and bone.

Authors:  Luigi di Filippo; Mauro Doga; Eugenia Resmini; Andrea Giustina
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 5.  Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects.

Authors:  Francesco Tecilazich; Anna Maria Formenti; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2021-12       Impact factor: 6.514

6.  Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era.

Authors:  Andrea Giustina; Ewen Legg; Bruno Mario Cesana; Stefano Frara; Pietro Mortini; Maria Fleseriu
Journal:  Endocrine       Date:  2021-01-07       Impact factor: 3.633

7.  A Pituitary Society update to acromegaly management guidelines.

Authors:  Maria Fleseriu; Beverly M K Biller; Pamela U Freda; Monica R Gadelha; Andrea Giustina; Laurence Katznelson; Mark E Molitch; Susan L Samson; Christian J Strasburger; A J van der Lely; Shlomo Melmed
Journal:  Pituitary       Date:  2020-10-20       Impact factor: 4.107

Review 8.  A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates.

Authors:  Emilio J Vélez; Suraj Unniappan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-23       Impact factor: 5.555

Review 9.  COVID-19 and the pituitary.

Authors:  Stefano Frara; Agnese Allora; Laura Castellino; Luigi di Filippo; Paola Loli; Andrea Giustina
Journal:  Pituitary       Date:  2021-05-03       Impact factor: 3.599

Review 10.  Towards an Earlier Diagnosis of Acromegaly and Gigantism.

Authors:  Jill Sisco; A J van der Lely
Journal:  J Clin Med       Date:  2021-03-26       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.